Peptide 'natty gear' claims on TikTok: what the science says

What did @.tatteredwizard actually say?

The creator pitched AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) as "one of the best tools you can use for energy, endurance, and recovery," crediting its ability to "mobilize fatty acids" for both fat loss and ATP production. They recommended stacking it with L-carnitine, creatine, and compounds like SS-31, MoTS-c (what they called "Mothsea"), and methylene blue. They also flagged that this stack can increase reactive oxygen species (ROS) and suggested controlling that with injectable glutathione or melatonin.

The video is clearly aimed at people who are already experimenting with research compounds, not first-timers. It moves fast, mixes legitimate biochemistry with some sloppy terminology, and recommends a genuinely complex stack without much safety context. That combination deserves a closer look.

Does the science back this up?

Partially, but with real caveats. AICAR activates AMPK (AMP-activated protein kinase), which is a legitimate metabolic pathway. The problem is that human evidence is thin, and the animal data is being stretched further than it should be.

AMPK activation by AICAR has been studied extensively in rodent models. A 2008 paper by Narkar et al. in Cell showed that AICAR improved running endurance in sedentary mice by 44%, which is the study most people in these communities are citing. That finding is real. What gets glossed over is that those were mice, the dosing was controlled, and the compound was being studied as a potential metabolic disease treatment, not a sports supplement. Human pharmacokinetic data on AICAR is largely drawn from its clinical use in cardiac surgery (it was briefly used as Acadesine), not athletic performance contexts.

The ATP claim is also worth unpacking. AICAR does not directly increase ATP. It mimics AMP, which signals low energy and activates AMPK, a sensor that then shifts the cell toward energy-producing processes. Saying it "heightens ATP" is an oversimplification that could mislead people about the mechanism.

What did they get wrong (or right)?

Credit where it is due: the ROS warning is legitimate. Several of the compounds mentioned, including methylene blue and MoTS-c, do interact with mitochondrial electron transport in ways that can increase oxidative stress under certain conditions. Mentioning antioxidant support alongside a mitochondria-targeting stack is not wrong. It is actually better safety framing than most content in this space provides.

Where things go sideways is the casual grouping of AICAR, SS-31, MoTS-c, and methylene blue as "endurance drugs" you just combine for "fantastic results." SS-31 (elamipretide) is a mitochondria-targeted peptide with some human trial data in heart failure, but its use in healthy athletes is entirely off-label and speculative. MoTS-c has almost no human data at all. Bundling these together as a recoverable stack, without any dosing context or acknowledgment that these compounds are not approved for human use outside of clinical research, is where this video starts doing real harm.

The injectable glutathione recommendation also needs scrutiny. IV glutathione has limited absorption evidence and variable safety data. Calling it out as a go-to antioxidant solution, without noting the risks of self-injection or that oral and liposomal forms exist, is incomplete at best.

What should you actually know?

AICAR is a research compound, not a regulated supplement. It is not approved by the FDA for athletic or general wellness use. Most of what we know about it comes from cell studies and rodent models, with very limited controlled human data outside of cardiac contexts.

The AMPK pathway AICAR targets is genuinely interesting science. Researchers like David Sabatini and others studying metabolic regulation have mapped out how AMPK interacts with mTOR, autophagy, and fatty acid oxidation. But interesting science in a lab does not mean safe or effective in a self-administered stack.

If you are drawn to this category of compounds, the honest read is that the human evidence is years behind the hype. A 2021 review by Bujak et al. in Cells outlined AMPK's therapeutic promise while noting that translating rodent findings to humans has repeatedly proven harder than expected. The ROS angle the creator raises is real biology, but the answer to oxidative stress from an unapproved research compound stack is not necessarily injectable glutathione. It might be not running that stack in the first place.

Bottom line

This video mixes real biochemistry with significant gaps in human evidence and makes a complex, unapproved compound stack sound more straightforward than it is. The creator gets points for raising ROS as a concern, but loses them for how casually they recommend these compounds together without regulatory or safety context. If you are considering anything in this stack, this TikTok is a starting point for a conversation with a physician, not a protocol.